Logo image of BKV

BKV CORPORATION (BKV) Stock Fundamental Analysis

NYSE:BKV - New York Stock Exchange, Inc. - US05603J1088 - Common Stock - Currency: USD

23.35  -1.29 (-5.24%)

Premarket: 23.71 +0.36 (+1.54%)

Fundamental Rating

2

Overall BKV gets a fundamental rating of 2 out of 10. We evaluated BKV against 210 industry peers in the Oil, Gas & Consumable Fuels industry. BKV may be in some trouble as it scores bad on both profitability and health. BKV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BKV was profitable.
BKV Yearly Net Income VS EBIT VS OCF VS FCFBKV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 100M -100M 200M 300M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.16%, BKV is in line with its industry, outperforming 50.74% of the companies in the same industry.
BKV has a Return On Equity (7.31%) which is in line with its industry peers.
The Return On Invested Capital of BKV (6.11%) is comparable to the rest of the industry.
BKV had an Average Return On Invested Capital over the past 3 years of 6.46%. This is significantly below the industry average of 28.74%.
Industry RankSector Rank
ROA 5.16%
ROE 7.31%
ROIC 6.11%
ROA(3y)3%
ROA(5y)N/A
ROE(3y)6.52%
ROE(5y)N/A
ROIC(3y)6.46%
ROIC(5y)N/A
BKV Yearly ROA, ROE, ROICBKV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 10 -10 20 -20 30

1.3 Margins

BKV has a Profit Margin of 11.95%. This is comparable to the rest of the industry: BKV outperforms 48.77% of its industry peers.
BKV's Operating Margin of 15.89% is in line compared to the rest of the industry. BKV outperforms 45.32% of its industry peers.
Industry RankSector Rank
OM 15.89%
PM (TTM) 11.95%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BKV Yearly Profit, Operating, Gross MarginsBKV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 20 -20

3

2. Health

2.1 Basic Checks

BKV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
BKV has about the same amout of shares outstanding than it did 1 year ago.
The debt/assets ratio for BKV has been reduced compared to a year ago.
BKV Yearly Shares OutstandingBKV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M
BKV Yearly Total Debt VS Total AssetsBKV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.54 indicates that BKV is not a great score, but indicates only limited risk for bankruptcy at the moment.
BKV's Altman-Z score of 2.54 is fine compared to the rest of the industry. BKV outperforms 71.43% of its industry peers.
BKV has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
BKV has a Debt to Equity ratio of 0.12. This is in the better half of the industry: BKV outperforms 77.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 2.54
ROIC/WACC0.73
WACC8.39%
BKV Yearly LT Debt VS Equity VS FCFBKV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 500M 1B

2.3 Liquidity

BKV has a Current Ratio of 0.90. This is a bad value and indicates that BKV is not financially healthy enough and could expect problems in meeting its short term obligations.
BKV's Current ratio of 0.90 is on the low side compared to the rest of the industry. BKV is outperformed by 69.95% of its industry peers.
BKV has a Quick Ratio of 0.90. This is a bad value and indicates that BKV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.90, BKV perfoms like the industry average, outperforming 40.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.9
BKV Yearly Current Assets VS Current LiabilitesBKV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 100M 200M 300M 400M 500M

1

3. Growth

3.1 Past

The earnings per share for BKV have decreased strongly by -71.49% in the last year.
Looking at the last year, BKV shows a decrease in Revenue. The Revenue has decreased by -5.09% in the last year.
EPS 1Y (TTM)-71.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-5.09%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, BKV will show a small growth in Earnings Per Share. The EPS will grow by 7.21% on average per year.
BKV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.36% yearly.
EPS Next Y-202.39%
EPS Next 2Y-11.14%
EPS Next 3Y7.21%
EPS Next 5YN/A
Revenue Next Year-29.78%
Revenue Next 2Y-6.57%
Revenue Next 3Y2.36%
Revenue Next 5YN/A

3.3 Evolution

BKV Yearly Revenue VS EstimatesBKV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
BKV Yearly EPS VS EstimatesBKV Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 1 -1

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.80, BKV is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of BKV is on the same level as its industry peers.
BKV's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.62.
With a Price/Forward Earnings ratio of 21.28, BKV is valued on the expensive side.
BKV's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. BKV is more expensive than 60.59% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, BKV is valued at the same level.
Industry RankSector Rank
PE 16.8
Fwd PE 21.28
BKV Price Earnings VS Forward Price EarningsBKV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BKV is valued a bit cheaper than the industry average as 64.04% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.62
BKV Per share dataBKV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.14%
EPS Next 3Y7.21%

0

5. Dividend

5.1 Amount

BKV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BKV CORPORATION

NYSE:BKV (2/21/2025, 8:04:01 PM)

Premarket: 23.71 +0.36 (+1.54%)

23.35

-1.29 (-5.24%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)02-26 2025-02-26/bmo
Inst Owners20.11%
Inst Owner Change-98.97%
Ins Owners4.84%
Ins Owner Change6.77%
Market Cap1.98B
Analysts84.62
Price Target29.47 (26.21%)
Short Float %8.27%
Short Ratio2.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.34%
Min Revenue beat(2)-15.25%
Max Revenue beat(2)-3.43%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.79%
PT rev (3m)12.74%
EPS NQ rev (1m)-31.92%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.03%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)1%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.8
Fwd PE 21.28
P/S 2.02
P/FCF N/A
P/OCF N/A
P/B 1.24
P/tB 1.25
EV/EBITDA 5.62
EPS(TTM)1.39
EY5.95%
EPS(NY)1.1
Fwd EY4.7%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS11.56
BVpS18.9
TBVpS18.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.16%
ROE 7.31%
ROCE 7.3%
ROIC 6.11%
ROICexc 6.2%
ROICexgc 6.25%
OM 15.89%
PM (TTM) 11.95%
GM N/A
FCFM N/A
ROA(3y)3%
ROA(5y)N/A
ROE(3y)6.52%
ROE(5y)N/A
ROIC(3y)6.46%
ROIC(5y)N/A
ROICexc(3y)6.87%
ROICexc(5y)N/A
ROICexgc(3y)6.94%
ROICexgc(5y)N/A
ROCE(3y)7.72%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA 0.5
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.9
Altman-Z 2.54
F-ScoreN/A
WACC8.39%
ROIC/WACC0.73
Cap/Depr(3y)119.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)19.38%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-202.39%
EPS Next 2Y-11.14%
EPS Next 3Y7.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.09%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-29.78%
Revenue Next 2Y-6.57%
Revenue Next 3Y2.36%
Revenue Next 5YN/A
EBIT growth 1Y-48.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year27.9%
EBIT Next 3Y44.75%
EBIT Next 5YN/A
FCF growth 1Y-166.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-64.75%
OCF growth 3YN/A
OCF growth 5YN/A